Our results reveal a distinct biphasic pattern in EV dynamics over the course of infection, characterized by a reduction in EV release from CD4+ T cells and CD14+ monocytes during the active phase, followed by a significant resurgence during and after antimonial therapy. This evidence concerns the gene CD14 and infection.